Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat neuronal protein 2 (LRRN2) is a single-pass transmembrane protein that belongs to the leucine-rich repeat superfamily, predicted to participate in cell adhesion and signal transduction and to function as a signaling receptor[1][2][3][4][6]. It plays a role in vertebrate nervous system development, notably in the guidance of motor axons during embryogenesis, where it acts downstream of regulators like Hoxb1 and Sonic hedgehog in chick neural development[1]. LRRN2 is also found to be amplified and overexpressed in malignant gliomas, suggesting a role in oncogenesis and making it a candidate gene in cancer-related chromosomal amplicons[2][3]. It is associated with other diseases, including autism spectrum disorder and ependymoma, though its precise molecular and pharmacological functions remain incompletely characterized[3]. The encoded protein shares homology with cell-adhesion molecules and signal-transducing receptors, but no approved drugs or known pharmacological modulators are currently described for this target[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat neuronal protein 2 (LRRN2).